Table 2.
Results of all participants’ outcome variables according to time point.
| Variables | Visit 1 (baseline, N=49) | Visit 2 (6 weeks, N=49) | Visit 3 (12 weeks, N=43) | |||||
| n (%) | mean (SD) | n (%) | mean (SD) | P value | n (%) | mean (SD) | P value | |
| 6MWDa (m) | 49 (100) | 433.429 (65.595) | 42 (86) | 448.095 (76.421) | .14 | 40 (93) | 471.250 (75.691) | .001 |
| mMRCb score | 49 (100) | 0.939 (0.659) | 45 (92) | 0.733 (0.618) | .04 | 43 (100) | 0.605 (0.821) | .02 |
| EQ-VASc score | 43 (88) | 76.047 (12.371) | N/Ad | N/A | N/A | 43 (100) | 82.093 (13.674) | .002 |
| EQ-5De score | 43 (88) | 7.535 (1.817) | N/A | N/A | N/A | 43 (100) | 6.930 (2.849) | .17 |
| PGAf score | N/A | N/A | 39 (80) | 13.769 (3.681) | N/A | 39 (91) | 15.077 (3.989) | .01 |
a6MWD: 6-minute walk distance.
bmMRC: modified Medical Research Council.
cEQ-VAS: EuroQol-visual analog scale.
dN/A: not applicable.
eEQ-5D: EuroQol 5 dimensions questionnaire.
fPGA: Patient Global Assessment.